Cite
HARVARD Citation
Yan, M. et al. (2022). A prospective, open-label, multicenter phase IV clinical trial on the safety and efficacy of lobaplatin-based chemotherapy in advanced breast cancer. Therapeutic advances in medical oncology. p. . [Online].